4//SEC Filing
Shendelman Shoshana 4
Accession 0001209191-23-059636
CIK 0001697532other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 8:01 PM ET
Size
11.8 KB
Accession
0001209191-23-059636
Insider Transaction Report
Form 4
Shendelman Shoshana
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock
2023-12-21+1,100,000→ 3,696,387 total - Award
Common Stock
2023-12-21+440,000→ 4,136,387 total
Holdings
- 1,750,000(indirect: See footnote)
Common Stock
- 290,280(indirect: See footnote)
Common Stock
- 88,397(indirect: See footnote)
Common Stock
- 1,492,094(indirect: See footnote)
Common Stock
- 709,720(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 21, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.
- [F2]Consists of compensatory Restricted Stock Units granted under the Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. These compensatory Restricted Stock Units are subject to both performance and time-based vesting requirements, subject to the reporting person continuing to provide services through each such date. The performance-based vesting requirements shall be satisfied upon the issuer's stock price trading at or above $6.00 per share for twenty consecutive trading days during a four-year performance period. The time-based vesting requirements shall be satisfied on the same schedule as applies to the time-based awards referenced in footnote (1) above.
- [F3]Through a grantor retained annuity trust.
- [F4]Through a family trust controlled by the reporting person's spouse.
- [F5]Through the reporting person's spouse.
- [F6]Through a family trust controlled by the reporting person.
- [F7]Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001775490
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 8:01 PM ET
- Size
- 11.8 KB